Burzynski Research Institute, Inc.
|
-0.01 USD
|
-1076.471%
|
Arch Therapeutics, Inc.
|
-2.27 USD
|
94.714%
|
Evofem Biosciences, Inc.
|
10.35 USD
|
101.159%
|
Nascent Biotech, Inc.
|
-0.01 USD
|
-795.522%
|
Rebus Holdings, Inc.
|
-0.03 USD
|
-273.832%
|
Santhera Pharmaceuticals Holding AG
|
5.95 USD
|
102.017%
|
Qrons Inc.
|
-0.06 USD
|
-105.832%
|
Adynxx, Inc.
|
- USD
|
Infinity%
|
Neon Bloom, Inc.
|
-0.00 USD
|
-7900.0%
|
Northwest Biotherapeutics, Inc.
|
-0.06 USD
|
-108.696%
|
ProtoKinetix, Incorporated
|
-0.01 USD
|
-1100.0%
|
Skye Bioscience, Inc.
|
-5.37 USD
|
97.765%
|
Eiger BioPharmaceuticals, Inc.
|
-50.78 USD
|
99.764%
|
Nanobac Pharmaceuticals, Incorporated
|
- USD
|
Infinity%
|
Institute of Biomedical Research Corp.
|
-0.05 USD
|
-133.01%
|
SQZ Biotechnologies Company
|
-2.76 USD
|
95.652%
|
Intellipharmaceutics International Inc.
|
-0.09 USD
|
-37.3%
|
Propanc Biopharma, Inc.
|
-0.02 USD
|
-406.329%
|
Mesoblast Limited
|
-0.09 USD
|
-34.68%
|
Marizyme, Inc.
|
-1.44 USD
|
91.667%
|
Genus plc
|
0.12 USD
|
200.0%
|
VioQuest Pharmaceuticals, Inc.
|
-2.33 USD
|
94.85%
|
Pharming Group N.V.
|
-0.02 USD
|
-645.342%
|
Therapeutic Solutions International, Inc.
|
-0.00 USD
|
-17042.857%
|
CNBX Pharmaceuticals Inc.
|
-0.42 USD
|
71.429%
|
Nymox Pharmaceutical Corporation
|
-0.10 USD
|
-24.352%
|
ContraFect Corporation
|
-124.97 USD
|
99.904%
|
PsyBio Therapeutics Corp.
|
-0.04 USD
|
-185.714%
|
Sienna Biopharmaceuticals, Inc.
|
- USD
|
Infinity%
|
RegeneRx Biopharmaceuticals, Inc.
|
-0.01 USD
|
-900.0%
|
IMV Inc.
|
-4.37 USD
|
97.254%
|
AXIM Biotechnologies, Inc.
|
-0.04 USD
|
-238.983%
|
MultiCell Technologies, Inc.
|
-0.00 USD
|
-119900.0%
|
ONE Bio Corp.
|
1.43 USD
|
108.392%
|
Accustem Sciences Inc.
|
-0.34 USD
|
64.706%
|
RVL Pharmaceuticals plc
|
-0.58 USD
|
79.31%
|
Arno Therapeutics, Inc.
|
- USD
|
Infinity%
|
Q BioMed Inc.
|
-0.08 USD
|
-53.649%
|
Emmaus Life Sciences, Inc.
|
-0.07 USD
|
-70.697%
|
Mosaic ImmunoEngineering Inc.
|
-0.33 USD
|
63.636%
|
Biomind Labs Inc.
|
-0.02 USD
|
-640.741%
|
American Oriental Bioengineering, Inc.
|
-781.24 USD
|
99.985%
|
Provectus Biopharmaceuticals, Inc.
|
-0.01 USD
|
-1521.622%
|
TetraLogic Pharmaceuticals Corporation
|
- USD
|
Infinity%
|
Oncotelic Therapeutics, Inc.
|
-0.02 USD
|
-503.015%
|
GlobeStar Therapeutics Corporation
|
-0.00 USD
|
-4900.0%
|
THC Farmaceuticals, Inc.
|
-0.00 USD
|
-14900.0%
|
Acro Biomedical Co., Ltd.
|
-0.26 USD
|
53.846%
|
Curative Biotechnology, Inc.
|
-0.01 USD
|
-1263.636%
|
GB Sciences, Inc.
|
-0.00 USD
|
-2826.829%
|
Alpha Cognition Inc.
|
-0.15 USD
|
20.0%
|
HST Global, Inc.
|
-0.03 USD
|
-330.108%
|
CSL Limited
|
2.73 USD
|
104.396%
|
Wesana Health Holdings Inc.
|
-0.05 USD
|
-139.521%
|
Halberd Corporation
|
-0.00 USD
|
-119900.0%
|
Enzolytics Inc.
|
-0.00 USD
|
-17042.857%
|
Agentix Corp.
|
-0.04 USD
|
-242.857%
|
Resverlogix Corp.
|
-0.01 USD
|
-745.07%
|
Nuo Therapeutics, Inc.
|
-0.08 USD
|
-59.151%
|
MetaStat, Inc.
|
- USD
|
Infinity%
|
argenx SE
|
-5.16 USD
|
97.674%
|
Enzon Pharmaceuticals, Inc.
|
0.00 USD
|
9330.769%
|
Endonovo Therapeutics, Inc.
|
0.03 USD
|
578.088%
|
RespireRx Pharmaceuticals Inc.
|
-0.04 USD
|
-236.134%
|
GeneThera, Inc.
|
- USD
|
Infinity%
|
Inhibitor Therapeutics, Inc.
|
-0.02 USD
|
-500.0%
|
AVAX Technologies, Inc.
|
-0.05 USD
|
-122.635%
|
Zenith Capital Corp.
|
-0.07 USD
|
-71.674%
|
Genscript Biotech Corporation
|
-0.05 USD
|
-164.317%
|
Ember Therapeutics, Inc.
|
-0.01 USD
|
-1804.762%
|
Anthera Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
Sigyn Therapeutics, Inc.
|
-3.77 USD
|
96.817%
|
WPD Pharmaceuticals Inc.
|
-0.00 USD
|
-23900.0%
|
Cotinga Pharmaceuticals Inc.
|
-0.09 USD
|
-31.435%
|
Kadimastem Ltd
|
-0.78 USD
|
84.615%
|
Helix BioMedix, Inc.
|
-4.70 USD
|
97.447%
|
VitaSpring Biomedical Co. Ltd.
|
- USD
|
Infinity%
|
Capstone Therapeutics Corp.
|
-36.39 USD
|
99.67%
|
BioStem Technologies, Inc.
|
-0.62 USD
|
80.645%
|
Oncology Pharma Inc.
|
- USD
|
Infinity%
|
Reve Technologies, Inc.
|
-0.01 USD
|
-908.403%
|
LadRx Corporation
|
0.68 USD
|
117.647%
|
Cell Source, Inc.
|
-0.17 USD
|
29.412%
|
Regen BioPharma, Inc.
|
0.29 USD
|
141.379%
|
Regen BioPharma, Inc.
|
0.26 USD
|
146.154%
|
NovAccess Global Inc.
|
-0.23 USD
|
47.826%
|
Affymax, Inc.
|
-0.39 USD
|
69.231%
|
Itoco Inc.
|
-0.01 USD
|
-1478.947%
|
Rasna Therapeutics, Inc.
|
-0.01 USD
|
-1100.0%
|
Pathfinder Cell Therapy, Inc.
|
-0.00 USD
|
-4700.0%
|
Mobile Lads Corp.
|
-0.01 USD
|
-2042.857%
|
CytoDyn Inc.
|
-0.05 USD
|
-126.843%
|
Claritas Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
NDT Pharmaceuticals Inc.
|
-0.00 USD
|
-23900.0%
|
NanoSphere Health Sciences Inc.
|
-0.02 USD
|
-440.541%
|
Alseres Pharmaceuticals, Inc.
|
-153.67 USD
|
99.922%
|
SYBLEU INC
|
-0.02 USD
|
-585.714%
|
Advanced Proteome Therapeutics Corporation
|
- USD
|
Infinity%
|
ImmunoCellular Therapeutics, Ltd.
|
-0.01 USD
|
-745.07%
|
International Stem Cell Corporation
|
-0.02 USD
|
-631.707%
|
Bioxytran, Inc.
|
-0.03 USD
|
-276.176%
|
GlobeImmune, Inc.
|
- USD
|
Infinity%
|
Predictive Technology Group, Inc.
|
- USD
|
Infinity%
|
ProText Mobility, Inc.
|
- USD
|
Infinity%
|
Cardax, Inc.
|
- USD
|
Infinity%
|
VG Life Sciences Inc.
|
-0.00 USD
|
-119900.0%
|
Kaleido Biosciences, Inc.
|
- USD
|
Infinity%
|
Advaxis, Inc.
|
-7.99 USD
|
98.498%
|
Adhera Therapeutics, Inc.
|
-1.18 USD
|
89.831%
|
RenovaCare, Inc.
|
- USD
|
Infinity%
|
Regnum Corp.
|
-0.03 USD
|
-252.941%
|
Innovation Pharmaceuticals Inc.
|
-0.01 USD
|
-1804.762%
|
Neutra Corp.
|
-0.00 USD
|
-119900.0%
|
Windtree Therapeutics, Inc.
|
-94.23 USD
|
99.873%
|
PureTech Health plc
|
-2.38 USD
|
94.958%
|
Coeptis Therapeutics, Inc.
|
-0.83 USD
|
85.542%
|
IXICO plc
|
-0.02 USD
|
-391.803%
|
IntelGenx Technologies Corp.
|
-0.06 USD
|
-111.268%
|
Gelesis Holdings, Inc.
|
-1.35 USD
|
91.111%
|
CSL Limited
|
5.47 USD
|
102.194%
|
Cellectis S.A.
|
-1.77 USD
|
93.22%
|